Advertorials
EMLy™
The AI platform turning months of biologics engineering into days
When Michelle Teng and Jacob Hurst cofounded Etcembly in the problem they were setting out to solve was one
Pharma Reimagined
The strategic evolution of CPHI & PMEC China
As the epicentre of the AsiaPacific pharmaceutical market CPHI PMEC China serves attendees
Where Generics Win
Pharmaceutical ingredients that make the difference
Excipients play an essential role in pharmaceutical formulations than theyre often given credit for so what do they really
Shaping Tomorrow’s Pharma with Sustainable Solutions
Advanced Separation, Thermal Efficiency & Hygienic Processing
As the pharmaceutical industry scales up to meet global demand manufacturers are under growing
Beyond Isolated Risk Scores: Integrating Contamination Controls with PDA/ANSI 03‑2025
The typical FMEAbased risk assessments that most of us are familiar are designed to evaluate risks in isolation whereas this standard strives to assess contamination risk under an integrated system of controls This is directly in line with the statement in Annex Section on Contamination Control Strategy CCS
Accelerating Study Start-up with Connected Study Build
In the current clinical trial landscape study build and startup have become increasingly complex Protocols are more sophisticated timelines are tighter and teams must often navigate multiple systems to prepare for execution When study setup is treated as a series of disconnected activities timelines stretch and the risk of rework increases
TRADITIONAL PHARMA FACILITIES
Time to rethink
In several recent cases companies have invested hundreds of millions of dollars in new plants only to face delayed integration
Almac Clinical Services
Driving Innovation and Supply-Chain Excellence Across APAC
The market context in the region at the time made establishing our APAC headquarters in Singapore
From Molecule to Market
Solving the fragmented approach in prefillable syringe development
Asia Pacific APAC is rapidly emerging as a global hub for biologics South Korea India Singapore and Thailand
Pharma 4.0
Driving the future of pharma manufacturing
Pharma adapted from Industry is tailored to meet the stringent regulatory demands of the pharmaceutical industry
